CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
50 hedge funds and large institutions have $58M invested in Concert Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
50
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.03M | |
| 2 | +$1.27M | |
| 3 | +$1.01M | |
| 4 |
Bank of New York Mellon
New York
|
+$559K |
| 5 |
Citigroup
New York
|
+$558K |
Top Sellers
| 1 | -$3.06M | |
| 2 | -$2.69M | |
| 3 | -$1.64M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$807K |